Actively Recruiting
Observational Registry to Collect Real-World Outcomes of the Edwards INSPIRIS RESILIA Aortic Valve in Patients Undergoing Aortic Valve Replacement
Led by Edwards Lifesciences · Updated on 2026-10-02
500
Participants Needed
15
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting real-world data on the Edwards INSPIRIS RESILIA Aortic Valve for patients who need replacement of their native or prosthetic aortic valve as their only heart valve procedure. This observational registry study aims to understand the hemodynamic and clinical outcomes of this valve in typical care settings. Up to 500 participants will be enrolled across up to 20 sites in Germany. Participants will receive the Edwards INSPIRIS RESILIA Aortic Valve as part of their surgical aortic valve replacement. The study involves following these patients after their valve implantation during the index procedure. This registry does not involve randomization or comparison groups, but rather observes outcomes after the routine use of this device. During the study, participants will be monitored with echocardiography and CT imaging before surgery as part of standard care. Researchers will collect data on heart valve function, including average mean and peak gradients, and the amount of valve leakage around and through the valve prior to discharge about 7 to 10 days after surgery and again at 3 months. Participants heart functional status will also be assessed at baseline and 3 months using the New York Heart Association classification. The total study duration extends through December 2026.
CONDITIONS
Brief Title
Real World Data Collection on the INSPIRIS RESILIA Aortic Valve
Research Team
S
Sabrina Hundt, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here